| Ovid Therapeutics Inc. | OVID | Kevin Joseph FitzgeraldDir | Apr 7 | A | 17,578 | $2.56 | $45K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 5 | SPLAN | 153 | $326.24 | $50K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 5 | SPLAN | 148 | $324.60 | $48K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 5 | SPLAN | 233 | $323.25 | $75K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 5 | SPLAN | 124 | $321.81 | $40K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 57 | $325.67 | $19K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 75 | $324.88 | $24K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 210 | $323.84 | $68K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 96 | $323.01 | $31K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 79 | $321.82 | $25K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 59 | $320.81 | $19K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 28 | $320.01 | $9K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 4 | SPLAN | 29 | $319.03 | $9K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVPDERIV | Mar 2 | APLAN | 8,105 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 3 | SPLAN | 359 | $321.58 | $115K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 3 | SPLAN | 722 | $320.51 | $231K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 3 | SPLAN | 282 | $318.62 | $90K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 3 | SPLAN | 289 | $316.55 | $91K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 37 | $332.64 | $12K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 94 | $331.93 | $31K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 81 | $330.85 | $27K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 170 | $329.71 | $56K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 100 | $328.71 | $33K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 329 | $327.67 | $108K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 392 | $326.81 | $128K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 258 | $325.63 | $84K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 90 | $324.65 | $29K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | SPLAN | 47 | $323.62 | $15K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Mar 2 | APLAN | 3,688 | $0.00 | — |
| Ovid Therapeutics Inc. | OVID | Kevin Joseph FitzgeraldDirDERIV | Feb 26 | A | 65,000 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Feb 23 | A | 158 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Feb 17 | SPLAN | 2,041 | $331.96 | $678K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Feb 13 | SPLAN | 1,959 | $310.08 | $607K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Feb 12 | APLAN | 4,000 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 13 | SPLAN | 122 | $374.33 | $46K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 13 | SPLAN | 280 | $372.93 | $104K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 13 | SPLAN | 485 | $371.24 | $180K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 13 | SPLAN | 644 | $370.00 | $238K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 13 | SPLAN | 562 | $368.76 | $207K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 13 | SPLAN | 197 | $367.52 | $72K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 15 | $377.82 | $6K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 19 | $375.65 | $7K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 14 | $374.44 | $5K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 2 | $372.46 | $745 |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 19 | $370.87 | $7K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 40 | $369.48 | $15K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 92 | $368.62 | $34K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 41 | $367.40 | $15K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 50 | $366.41 | $18K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 220 | $365.56 | $80K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 199 | $364.83 | $73K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 47 | $363.55 | $17K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 73 | $362.38 | $26K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 98 | $361.45 | $35K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 155 | $360.22 | $56K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 85 | $359.14 | $31K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 123 | $358.18 | $44K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 96 | $357.17 | $34K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 41 | $356.09 | $15K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 42 | $355.16 | $15K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 12 | SPLAN | 39 | $353.95 | $14K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Jan 11 | APLAN | 3,800 | $0.00 | — |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVPDERIV | Nov 17 | MPLAN | 8,161 | $0.00 | —? |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 295 | $463.08 | $137K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 323 | $461.96 | $149K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 707 | $460.84 | $326K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 622 | $459.89 | $286K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 794 | $458.41 | $364K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 262 | $457.39 | $120K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 364 | $456.25 | $166K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 368 | $455.24 | $168K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 129 | $451.51 | $58K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 96 | $450.09 | $43K |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | SPLAN | 8,168 | $449.00 | $3.7M |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | Kevin Joseph FitzgeraldEVP | Nov 17 | MPLAN | 8,161 | $119.13 | $972K |